St. Vincent’s University Hospital reduces DNA rate to 10.5% resulting in massive cost savings
St. Vincent’s University Hospital reduces DNA rate to 10.5% resulting in massive cost savings.
St. Vincent’s University Hospital has been using Grapevine’s Defero product since early 2009 to send automated appointment reminders to patients and to try to reduce the hospital’s DNA rate from just over 24% to the HSE target of 10%. Since 2009 the introduction of Defero has seen the hospital’s DNA rate fallen from an initial 20.4% in 2009 to 10.5% in February 2011. As well as providing a better quality service to its patients, the hospital has reduced the cost of missed appointments from over €2 million per annum to just over €1.3 million providing massive savings annually.